Your browser doesn't support javascript.
loading
Treatment of De-Differentiated Liposarcoma in the Era of Immunotherapy.
Zhou, Maggie Y; Bui, Nam Q; Charville, Gregory W; Ganjoo, Kristen N; Pan, Minggui.
Affiliation
  • Zhou MY; Sarcoma Program, Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94304, USA.
  • Bui NQ; Sarcoma Program, Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94304, USA.
  • Charville GW; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94304, USA.
  • Ganjoo KN; Sarcoma Program, Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94304, USA.
  • Pan M; Sarcoma Program, Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94304, USA.
Int J Mol Sci ; 24(11)2023 May 31.
Article in En | MEDLINE | ID: mdl-37298520
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / Liposarcoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / Liposarcoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2023 Type: Article Affiliation country: United States